BIOMAT Database Logo BIOMAT Database Logo

Effects of synthetic biologically active peptides on giant neurones identified in the left buccal ganglion of an African giant snail (Achatina fulica Férussac). 1988

T Matsuoka, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
Department of Physiology, Gifu University School of Medicine, Japan.

1. The effects of synthetic biologically active peptides, including Met-enkephalin, substance P, oxytocin, Arg-vasopressin, proctolin and FMRFamide, on the following four buccal neurones were examined: d-LBAN (dorsal-left buccal anterior neurone), d-LBMN (dorsal-left buccal medial neurone), d-LBCN (dorsal-left buccal central neurone) and d-LBPN (dorsal-left buccal posterior neurone). These peptides were examined at 10(-4) M. 2. Oxytocin excited d-LBAN and slightly excited d-LBCN, while this inhibited d-LBMN. Arg-vasopressin excited slightly d-LBAN and d-LBCN, but this had some times no effect. FMRFamide inhibited d-LBAN, and slightly inhibited d-LBCN. 3. No direct synaptic connection from the two ventral cerebral giant neurones, v-LCDN and v-RCDN, to the four buccal giant neurones was found, though the two cerebral neurones innervate the cerebro-buccal connectives.

UI MeSH Term Description Entries
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002610 Cheek The part of the face that is below the eye and to the side of the nose and mouth. Bucca,Buccas,Cheeks
D005724 Ganglia Clusters of multipolar neurons surrounded by a capsule of loosely organized CONNECTIVE TISSUE located outside the CENTRAL NERVOUS SYSTEM.
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

T Matsuoka, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
Effects of synthetic peptides on giant neurones identified in the ganglia of an African giant snail (Achatina fulica Férussac). IV.
January 1987, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
T Matsuoka, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
Effects of biologically active peptides on the excitability of identifiable giant neurones of an African giant snail (Achatina fulica férussac).
September 1977, Neuropharmacology,
T Matsuoka, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
Further study of effects of synthetic peptides on identifiable giant neurones of an African giant snail (Achatina fulica Férussac).
January 1988, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
T Matsuoka, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
Effects of synthetic peptides on giant neurons identified in the ganglia of an African giant snail (Achatina fulica Férussac)--II.
January 1987, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
T Matsuoka, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
Acetylcholine-induced hyperpolarization in identified neurones of the African giant snail (Achatina fulica Férussac).
May 1986, Brain research,
T Matsuoka, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
Modification of effects of biologically active peptides, caused by enzyme treatment, on the excitability of identifiable giant neurones of an African giant snail (Achatina fulica Férussac).
February 1977, Experientia,
T Matsuoka, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
Inhibitory effects of aromatic oligopeptides on the excitability of identifiable giant neurones of an African giant snail (Achatina fulica Férussac).
January 1979, Archives internationales de pharmacodynamie et de therapie,
T Matsuoka, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
Effects of compounds related to beta-hydroxyglutamic acid (BHGA) on identifiable giant neurones of an African giant snail (Achatina fulica Férussac).
November 1987, European journal of pharmacology,
T Matsuoka, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
Pharmacological characteristics of four giant neurons identified in the cerebral ganglia of an African giant snail (Achatina fulica Férussac).
January 1985, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
T Matsuoka, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
Effects of catecholamine and monophenolamine agonists on identifiable giant neurones, sensitive to these amines, of an African giant snail (Achatina fulica Férussac).
May 1986, European journal of pharmacology,
Copied contents to your clipboard!